Search Results 691-700 of 14008 for anti-TNF drugs

  1. Xylazine - Mayo Clinic

    Medicines may help treat the symptoms of withdrawal. Xylazine overdose. When xylazine is mixed with opioids or alcohol, the risk of overdose is even higher.

  2. Calcipotriene (topical route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

    Etanercept (or biosimilar) treatment four weeks prior to randomization;; Adalimumab (or biosimilar) treatment ten weeks prior to randomization;; Other TNF or ...

  4. Non Clinical Trials

    Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...

  5. Undecylenic acid (topical route) - Mayo Clinic

    Compound undecylenic acid belongs to the group of medicines called antifungals. It is used to treat some types of fungus infections. However, compound ...

  6. Mitoxantrone (intravenous route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Autoimmune liver disease (positive anti-mitochondrial antibody and ...

  8. Science Saturday: Time tempers anthracyclines into a toxin or treatment for cancer - Mayo Clinic News Network

    But in some cases, the drugs used to treat cancer can cause other health problems during treatment or later. One example is a class of drugs called ...

  9. Genetic testing proves beneficial in prescribing effective blood thinners - Mayo Clinic News Network

    Anti-platelet drugs are given to prevent complications from blood clotting ... drug would benefit from the other anti-platelet medications. The meta ...

  10. Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma (ODYSSEY RCC) - Mayo Clinic

    The purpose of this study is to determine distinct patterns of change in the quality of life and symptom burden in mRCC patients receiving therapy.